Dolton, Garry, Thomas, Hannah, Tan, Li Rong, Rius Rafael, Cristina ORCID: https://orcid.org/0000-0002-1896-1649, Doetsch, Stephanie, Ionescu, Giulia-Andreea, Cardo, Lucia F., Crowther, Michael D., Behiry, Enas, Morin, Théo, Caillaud, Marine E., Srai, Devinder, Parolini, Lucia, Hasan, Md Samiul, Fuller, Anna, Topley, Katie, Wall, Aaron, Hopkins, Jade R., Omidvar, Nader, Alvares, Caroline ORCID: https://orcid.org/0000-0003-4391-9802, Zabkiewicz, Joanna ORCID: https://orcid.org/0000-0003-0951-3825, Frater, John, Szomolay, Barbara ORCID: https://orcid.org/0000-0002-5375-5533 and Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135
2025.
MHC-related protein 1-restricted recognition of cancer via a semi-invariant TCR-α chain.
The Journal of Clinical Investigation
135
(1)
, e181895.
10.1172/JCI181895
|
|
|
Halilovic, Melisa, Abdelsalam, Mohamed, Zabkiewicz, Joanna ORCID: https://orcid.org/0000-0003-0951-3825, Lazenby, Michelle, Alvares, Caroline ORCID: https://orcid.org/0000-0003-4391-9802, Schmidt, Matthias, Brenner, Walburgis, Najafi, Sara, Oehme, Ina, Hieber, Christoph, Zeyn, Yanira, Bros, Matthias, Sippl, Wolfgang and Krämer, Oliver H.
2024.
Selective degradation of mutant FMS-like tyrosine kinase-3 requires BIM-dependent depletion of heat shock proteins.
Leukemia
38
, pp. 2561-2572.
10.1038/s41375-024-02405-5
|
|
|
Jonas, Brian A., Hou, Jing-Zhou, Roboz, Gail J., Alvares, Caroline L. ORCID: https://orcid.org/0000-0003-4391-9802, Jeyakumar, Deepa, Edwards, John R., Erba, Harry P., Kelly, Richard J., Röllig, Christoph, Fiedler, Walter, Brackman, Deanna, Siddani, Satya R., Chyla, Brenda, Hilger-Rolfe, Jacqueline and Watts, Justin M.
2023.
A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia.
Hematological Oncology
41
(4)
, pp. 743-752.
10.1002/hon.3159
|
|
|
Chiriches, Claudia ORCID: https://orcid.org/0000-0003-3758-1892, Nicolaisen, Nathalie, Wieske, Maria, Elhaddad, Heba, Mehmetbeyoglu, Ecmel, Alvares, Caroline ORCID: https://orcid.org/0000-0003-4391-9802, Becher, Dörte, Hole, Paul, Ottmann, Oliver Gerhard ORCID: https://orcid.org/0000-0001-9559-1330 and Ruthardt, Martin ORCID: https://orcid.org/0000-0003-1021-3811
2022.
Understanding a high-risk acute myeloid leukemia by analyzing the interactome of its major driver mutation.
PLoS Genetics
18
(10)
, e1010463.
10.1371/journal.pgen.1010463
|
|
|
Zabkiewicz, Joanna ORCID: https://orcid.org/0000-0003-0951-3825, Lazenby, Michelle, Edwards, Gareth, Bygrave, Ceri A., Omidvar, Nader, Zhuang, Lihui, Knapper, Steve ORCID: https://orcid.org/0000-0002-6405-4441, Guy, Carol, Hills, Robert K. ORCID: https://orcid.org/0000-0003-0166-0062, Burnett, Alan K. and Alvares, Caroline L. ORCID: https://orcid.org/0000-0003-4391-9802
2020.
Combination of a mitogen‐activated protein kinase inhibitor with the tyrosine kinase inhibitor pacritinib combats cell adhesion‐based residual disease and prevents re‐expansion of FLT3 ‐ITD acute myeloid leukaemia.
British Journal of Haematology
191
(2)
, pp. 231-242.
10.1111/bjh.16665
|
|
|



Up a level